Supraspinatus Tendinitis — Effect of Kinesotaping on Management of Supraspinatus Tendinitis
Citation(s)
3 Cubala A, Sniegocki M, Hoffman J, et al. Use of the kinesio taping method in painful shoulder syndrome. Medical and Biological Sciences2012;26:71-6
7 Akbaba YA, Mutlu EK, Altun S, Gümüsoglu G, Çelik D. The effects of Kinesio Tape application with different verbal input given to with patients with rotator cuff tear. Orthopaedic Journal of Sports Medicine. 2017;5(2 suppl2):2325967117S00058.
de Oliveira FCL, de Fontenay BP, Bouyer LJ, Desmeules F, Roy JS Effects of kinesiotaping added to a rehabilitation programme for patients with rotator cuff tendinopathy: protocol for a single-blind, randomised controlled trial addressing symptoms, functional limitations and underlying deficits. BMJ Open. 2017 Sep 24;7(9):e017951. doi: 10.1136/bmjopen-2017-017951.
Drouin JL, McAlpine CT, Primak KA, Kissel J The effects of kinesiotape on athletic-based performance outcomes in healthy, active individuals: a literature synthesis. J Can Chiropr Assoc. 2013 Dec;57(4):356-65.
Kaya DO, Baltaci G, Toprak U, Atay AO The clinical and sonographic effects of kinesiotaping and exercise in comparison with manual therapy and exercise for patients with subacromial impingement syndrome: a preliminary trial. J Manipulative Physiol Ther. 2014 Jul-Aug;37(6):422-32. doi: 10.1016/j.jmpt.2014.03.004. Epub 2014 Aug 6.
Kim MH, Oh JS Effects of humeral head compression taping on the isokinetic strength of the shoulder external rotator muscle in patients with rotator cuff tendinitis. J Phys Ther Sci. 2015 Jan;27(1):121-2. doi: 10.1589/jpts.27.121. Epub 2015 Jan 9.
Lin JJ, Hung CJ, Yang PL The effects of scapular taping on electromyographic muscle activity and proprioception feedback in healthy shoulders. J Orthop Res. 2011 Jan;29(1):53-7. doi: 10.1002/jor.21146.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
